Results: We have analysed CSF from 8 glioma patients where the mutation in IDH1 has been confirmed by sequencing the tumour tissue, as well as 6 CSF samples from glioma patients with wild-type IDH1, and two healthy controls. Here, IDH1 is linked to neoplasm.